KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$10.15M	-
CFO	Gall Matthew	235.0K	$1.07M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 17, 2023	Sinha Vikas84	See Remarks	Sell	2,490	$1.63	$4,061.44	-0.2%	-57.7%	-65.1%
Nov 17, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	403	$1.63	$657.33	-0.3%	-57.7%	-65.1%
Oct 20, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	715	$1.56	$1,115.78	-0.3%	-54.3%	-48.8%
Oct 20, 2023	Sinha Vikas84	See Remarks	Sell	2,707	$1.56	$4,219.54	-0.1%	-54.3%	-48.8%
Oct 19, 2023	Brainard Diana85	Chief Executive Officer	Sell	8,581	$1.58	$13,557.98	-1.0%	-57.0%	-50.8%
Oct 3, 2023	Brainard Diana85	Chief Executive Officer	Sell	1,325	$1.98	$2,618.60	-0.1%	-66.4%	-59.8%
Oct 3, 2023	Sinha Vikas84	See Remarks	Sell	755	$1.98	$1,492.11	-	-66.4%	-59.8%
Oct 3, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	222	$1.98	$438.74	-0.2%	-66.4%	-59.8%
Aug 18, 2023	Brainard Diana85	Chief Executive Officer	Sell	15,416	$2.57	$39,664.01	-0.9%	-41.9%	-73.8%
Aug 17, 2023	Sinha Vikas84	See Remarks	Sell	10,516	$2.50	$26,242.68	-0.9%	-32.0%	-69.9%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC